Role of TLR7 expression in cancer: impact on immune activation and prognostic evaluation
J Transl Med
.
2024 Jul 29;22(1):696.
doi: 10.1186/s12967-024-05504-0.
Authors
Jiafeng Liang
1
,
Jie Huang
1
,
Yi Tang
1
,
Minna Zhang
1
,
Lucheng Zhu
2
,
Bing Xia
3
Affiliations
1
Department of Thoracic Oncology, Hangzhou Cancer Hospital, No.34 Yanguan Lane, Shangcheng District, Hangzhou, 310002, China.
2
Department of Thoracic Oncology, Hangzhou Cancer Hospital, No.34 Yanguan Lane, Shangcheng District, Hangzhou, 310002, China. zhulucheng1@outlook.com.
3
Department of Thoracic Oncology, Hangzhou Cancer Hospital, No.34 Yanguan Lane, Shangcheng District, Hangzhou, 310002, China. bingxia_hzch@163.com.
PMID:
39075490
PMCID:
PMC11287839
DOI:
10.1186/s12967-024-05504-0
No abstract available
Publication types
Letter
MeSH terms
Humans
Neoplasms* / immunology
Prognosis
Toll-Like Receptor 7* / genetics
Toll-Like Receptor 7* / metabolism
Substances
Toll-Like Receptor 7
TLR7 protein, human
Grants and funding
2022KY978/Medical Science and Technology Project of Zhejiang Province
2022KY980/Medical Science and Technology Project of Zhejiang Province
202004A19/Hangzhou Science and Technology Plan Project